ACETAMINOPHEN

First approved in 1950

Details

Stereochemistry	ACHIRAL
Molecular Formula	C8H9NO2
Molecular Weight	151.1629
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=Nc1ccc(cc1)O)O

InChI

InChIKey=RZVAJINKPMORJF-UHFFFAOYSA-N

InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)

HIDE SMILES / InChI

Molecular Formula	C8H9NO2
Molecular Weight	151.1629
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019872Orig1s044lbl.pdf

Acetaminophen, also known as paracetamol, is commonly used for its analgesic and antipyretic effects. Its therapeutic effects are similar to salicylates, but it lacks anti-inflammatory, antiplatelet, and gastric ulcerative effects. Acetaminophen (USAN) or Paracetamol (INN) is a widely used analgesic and antipyretic drug that is used for the relief of fever, headaches, and other minor aches and pains. It is a major ingredient in numerous cold and flu medications and many prescription analgesics. It is extremely safe in standard doses, but because of its wide availability, deliberate or accidental overdoses are not uncommon. Acetaminophen, unlike other common analgesics such as aspirin and ibuprofen, has no anti-inflammatory properties or effects on platelet function, and it is not a member of the class of drugs known as non-steroidal anti-inflammatory drugs or NSAIDs. At therapeutic doses, acetaminophen does not irritate the lining of the stomach nor affect blood coagulation, kidney function, or the fetal ductus arteriosus (as NSAIDs can). Acetaminophen is thought to act primarily in the CNS, increasing the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin (PG) synthesis. Unlike NSAIDs, acetaminophen does not inhibit cyclooxygenase in peripheral tissues and, thus, has no peripheral anti-inflammatory affects. Acetaminophen indirectly blocks COX, and that this blockade is ineffective in the presence of peroxides. This might explain why acetaminophen is effective in the central nervous system and in endothelial cells but not in platelets and immune cells, which have high levels of peroxides. Studies also report data suggesting that acetaminophen selectively blocks a variant of the COX enzyme that is different from the known variants COX-1 and COX-2. This enzyme is now referred to as COX-3. Its exact mechanism of action is still poorly understood, but future research may provide further insight into how it works. The antipyretic properties of acetaminophen are likely due to direct effects on the heat-regulating centers of the hypothalamus resulting in peripheral vasodilation, sweating and hence heat dissipation.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Cyclooxygenase 87 Target ID: CHEMBL2094253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/?term=15662292	Inhibitor 7701	Arthritis Backache Common cold Fever Headache

Conditions

Condition	Modality	Targets	Highest Phase	Product
Arthritis 85 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019872Orig1s044lbl.pdf	Palliative	Cyclooxygenase	Approved 7997	TYLENOL Approved Use Uses temporarily relieves minor aches and pains due to: minor pain of arthritis, muscular aches, backache, premenstrual abd menstrual cramps, the common cold, headache, toochache; temporary reduce fever Launch Date 757987200000
Backache 14 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019872Orig1s044lbl.pdf	Palliative	Cyclooxygenase	Approved 7997	TYLENOL Approved Use Uses temporarily relieves minor aches and pains due to: minor pain of arthritis, muscular aches, backache, premenstrual abd menstrual cramps, the common cold, headache, toochache; temporary reduce fever Launch Date 757900800000
Common cold 62 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019872Orig1s044lbl.pdf	Palliative	Cyclooxygenase	Approved 7997	TYLENOL Approved Use Uses temporarily relieves minor aches and pains due to: minor pain of arthritis, muscular aches, backache, premenstrual abd menstrual cramps, the common cold, headache, toochache; temporary reduce fever Launch Date 757900800000
Fever 20 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019872Orig1s044lbl.pdf	Palliative	Cyclooxygenase	Approved 7997	TYLENOL Approved Use Uses temporarily relieves minor aches and pains due to: minor pain of arthritis, muscular aches, backache, premenstrual abd menstrual cramps, the common cold, headache, toochache; temporary reduce fever Launch Date 757900800000
Headache 43 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019872Orig1s044lbl.pdf	Palliative	Cyclooxygenase	Approved 7997	TYLENOL Approved Use Uses temporarily relieves minor aches and pains due to: minor pain of arthritis, muscular aches, backache, premenstrual abd menstrual cramps, the common cold, headache, toochache; temporary reduce fever Launch Date 757900800000

C_max

Value	Dose	Co-administered	Analyte	Population
28 μg/mL DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204767s000lbl.pdf	1000 mg single, intravenous dose: 1000 mg route of administration: Intravenous experiment type: SINGLE co-administered:		ACETAMINOPHEN plasma	Homo sapiens population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
43 μg × h/mL DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204767s000lbl.pdf	1000 mg single, intravenous dose: 1000 mg route of administration: Intravenous experiment type: SINGLE co-administered:		ACETAMINOPHEN plasma	Homo sapiens population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
2.4 h DRUG LABEL https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204767s000lbl.pdf	1000 mg single, intravenous dose: 1000 mg route of administration: Intravenous experiment type: SINGLE co-administered:		ACETAMINOPHEN plasma	Homo sapiens population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN

Overview

CYP3A4	CYP2C9	CYP2D6	hERG
substrate 1470	substrate 865	substrate 1038

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer
UGT1A6 94 UGT2B15 56 hOCT1 8	CYP1A1 302 CYP1A2 892 CYP2A6 452 CYP2B6 575 CYP2C19 830 CYP2E1 567 UGT1A1 358 UGT1A3 358 UGT1A4 295 UGT1A6 258 UGT1A7 197 UGT1A8 242 UGT1A9 327 UGT1A10 247 UGT2B4 213 UGT2B7 329 UGT2B15 165 UGT2B17 184 SULT2A1 17 SULT1A3/4 2 SULT1E1 8

Drug as perpetrator

Target	Modality	Activity
hOCT1 8	inhibitor 2614 Sources: https://pubmed.ncbi.nlm.nih.gov/12388633/ Page: -	no
UGT1A6 126	inhibitor 2614 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes [Ki 2300 uM]
UGT2B15 56	inhibitor 2614 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes [Ki 5300 uM]

Drug as victim

Target	Modality	Activity
CYP3A4 1470	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	major
CYP2A6 452	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	no
CYP2B6 575	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	no
UGT1A3 358	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	no
UGT1A4 295	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	no
UGT2B17 184	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	no
UGT2B4 213	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	no
SULT1A3/4 2	substrate 2752 Sources: https://pubmed.ncbi.nlm.nih.gov/18232020/ Page: -	yes [Km 1500 uM]
SULT1E1 8	substrate 2752 Sources: https://pubmed.ncbi.nlm.nih.gov/18232020/ Page: -	yes [Km 1900 uM]
UGT2B15 165	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes [Km 2300 uM]
SULT2A1 17	substrate 2752 Sources: https://pubmed.ncbi.nlm.nih.gov/18232020/ Page: -	yes [Km 3700 uM]
UGT1A6 258	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes [Km 4000 uM]
UGT1A1 358	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes [Km 5500 uM]
CYP1A1 302	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	yes
CYP1A2 892	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	yes
CYP2C19 830	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	yes
CYP2C9 865	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	yes
CYP2D6 1038	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	yes
CYP2E1 567	substrate 2752 Sources: https://www.tandfonline.com/doi/pdf/10.1080/00498250802512830?needAccess=true Page: 6	yes
UGT1A10 247	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes
UGT1A7 197	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes
UGT1A8 242	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes
UGT1A9 327	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes
UGT2B7 329	substrate 2752 Sources: https://pubs.acs.org/doi/10.1021/tx050317i Page: -	yes

Sourcing

Vendor/Aggregator	ID	URL
1PlusChem LLC	1P0034CJ
A2B Chem	AB44803
AA Blocks	AA0033T3
ACT Chemical	ACT06727
AK Scientific	H865
APExBIO	B3532
AbovChem LLC	HY-66005
Accela ChemBio Inc	SY001162
Achemo BB	AC-22304
Acros Organics	10233
Alfa Chemistry	A11240
Alfa Chemistry	ACM103902
Alinda	IBS-E0000942
Alinda	IVK/0069399
Apollo Scientific	BIA1214
Apollo Scientific	OR3962
BOC Sciences	103-90-2
Bide Pharmatech	BD112079
BlocksMatrix Scientific	139844
Bosche Scientific	A1916
Capot Chemical	17726
Cayman Chemical	10024
Chem Scene	CS-2819
ChemDiv	0099-0228
Chemik	CHB83103
Combi-Blocks	QE-2029
Compound Cloud	1983
Compound Cloud	BCC0115037
Enamine	BBV-46875617
Enamine	BBV-92912770
Enamine	BBV-92934724
Enamine	EN300-17510
Enamine	PV-001837354716
Fluorochem	5037
Frontier Scientific Services	500008847
Frontier Scientific Services	502045822
Hairui	HR124390
Hangzhou APIChem Technology	AC-23969
Hangzhou Yuhao Chemical Technology	RT12770
Heteroz	A0029
HongKong Chemhere	SCF03619
IBScreen	BB_SC-07122
Innovapharm	BBS-00008094
Innovapharm	STT-00213638
Lab Network	LN00195030
Lab Seeker	SC-19146
Lab Seeker	SC-53062
Life Chemicals	F3096-1731
MedChem Express	HY-66005
MolPort	MolPort-000-150-777
Molnova	M10198
MuseChem	I000233
MuseChem	R004616
NCI Plated 2007	109028
NCI Plated 2007	3991
Nanjing Pope Bio-tech	NSTH-D05802
Norris Pharm	NSTH-D05802
Norris Pharm	NSZB-A167846
Norris Pharm	NSZB-A179161
Oakwood	5037
Otava	125160280
Pharmeks	PHBB_SC-08449
Princeton BioMolecular Research	OSSK_712518
Ryan Scientific	107-57829
Ryan Scientific	116-92801
Ryan Scientific	Clofibric_acid
ShangHai Biochempartner	BCP23431
Sigma Aldrich	1003009
Sigma Aldrich	1003009\|USP
Sigma Aldrich	A-064
Sigma Aldrich	A2794
Sigma Aldrich	A2794\|SIAL
Sigma Aldrich	A3035
Sigma Aldrich	A3035\|SIAL
Sigma Aldrich	A5000
Sigma Aldrich	A5000\|SIAL
Sigma Aldrich	A7085
Sigma Aldrich	A7085\|SIAL
Sigma Aldrich	A7302
Sigma Aldrich	A7302\|ALDRICH
Sigma Aldrich	BP371
Sigma Aldrich	BP371\|SIAL
Sigma Aldrich	P0300000
Sigma Aldrich	P0300000\|SIAL
Sigma Aldrich	PHR1005
Sigma Aldrich	PHR1005\|SIAL
Sigma Aldrich	S829218
Sigma Aldrich	S829218\|ALDRICH
Sigma Aldrich	Y0001781
Sigma Aldrich	Y0001781\|SIAL
StruChem	SC-19146
SynQuest	4656-1-W7
SynQuest	62890
TargetMol	T0065
Tetrahedron	TS40999
TimTec	SBB043758
TimTec	ST45179777
TimTec	ST50446317
Tocris	1706
Toronto Research Chemicals	A161220
Toronto Research Chemicals	KIT2470
Vitas-M Laboratory	BBL005229
Vitas-M Laboratory	STL140694
W&J PharmaChem	50C508902
Wonderchem	WD02B3R
ZINC	ZINC000013550868	http://zinc15.docking.org/substances/ZINC000013550868
eMolecules	207153871
eMolecules	27677450
eMolecules	300480808
eMolecules	474380
mcule	MCULE-3844920617
mcule	MCULE-7154806856

PubMed

Title	Date	PubMed
The degradation of paracetamol (4-hydroxyacetanilide) and other substituted acetanilides by a Penicillium species.	1975	1082294
Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test.	1976 Dec 13	1036573
Isolated acute renal failure due to paracetamol intoxication in an alcoholic patient.	1999	10529635
Paracetamol-induced fulminant hepatic failure in a child after 5 days of therapeutic doses.	1999	10447915
Assay to detect inhibitory substances in serum of patients with acute liver failure.	1999 Feb	10212046
Characteristics and risk factors of acetaminophen-induced hepatitis in Taiwan.	1999 Jun	10389295
Acetaminophen (paracetamol) levels in human tears.	1999 Oct	10519453
Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure.	1999 Oct	10515538
The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy.	2000 Apr	10811468
A hepatotoxic dose of acetaminophen modulates expression of BCL-2, BCL-X(L), and BCL-X(S) during apoptotic and necrotic death of mouse liver cells in vivo.	2000 Jan	10663392
Cerebral edema with herniation during acetaminophen-induced fulminant hepatic failure.	2000 Jul	10915174
Establishment of a human hepatoma cell line, HLE/2E1, suitable for detection of p450 2E1-related cytotoxicity.	2000 Oct	11212141
Mechanism of action of acetaminophen: is there a cyclooxygenase 3?	2000 Oct	11113024
Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure.	2000 Oct	11006363
Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice.	2000 Oct 15	11032766
Effects of acetaminophen administration to patients in intensive care.	2000 Sep	11089781
A prospective study of gastric mucosal ischaemia in paracetamol-induced acute liver failure.	2000 Sep	11089752
Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules.	2001 Feb	11217114
Effect of coadministered drugs and ethanol on the binding of therapeutic drugs to human serum in vitro.	2001 Feb	11206047
Management of drug-induced liver disease.	2001 Feb	11177693
Postoperative analgesia at home after ambulatory hand surgery: a controlled comparison of tramadol, metamizol, and paracetamol.	2001 Feb	11159230
Stroke severity determines body temperature in acute stroke.	2001 Feb	11157175
Thermodynamic analysis of compact formation; compaction, unloading, and ejection. II. Mechanical energy (work) and thermal energy (heat) determinations of compact unloading and ejection.	2001 Feb 1	11165093
Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat.	2001 Feb 1	11162779
Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media.	2001 Feb 10	11159657
ABC of diseases of liver, pancreas, and biliary system. Other causes of parenchymal liver disease.	2001 Feb 3	11157536
Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches.	2001 Jan	11215692
NSAID impairment of orthodontic tooth movement.	2001 Jan	11197570
Separation of cold medicine ingredients by capillary electrophoresis.	2001 Jan	11197163
Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain.	2001 Jan	11196522
Successful use of propranolol in migraine associated with electroconvulsive therapy.	2001 Jan	11168610
The dark side of a 'detoxification' mechanism.	2001 Jan	11165662
A comparison of the effect of nitroparacetamol and paracetamol on liver injury.	2001 Jan	11156555
One hundred percent online identity check of pharmaceutical products by near-infrared spectroscopy on the packaging line.	2001 Jan	11154898
Preoperative rectal diclofenac versus paracetamol for tonsillectomy: effects on pain and blood loss.	2001 Jan	11152033
Treatment with paracetamol in infants.	2001 Jan	11152028
Safety of childhood acetaminophen overdose.	2001 Jan	11145785
Prevention of acetaminophen-induced liver toxicity by 2(R,S)-n-propylthiazolidine-4(R)-carboxylic acid in mice.	2001 Jan 15	11163339
Unexpected and pronounced antinociceptive synergy between spinal acetaminophen (paracetamol) and phentolamine.	2001 Jan 26	11165231

Patents

Sample Use Guides

In Vivo Use Guide

2 caplets every 8 hours with water; don't take more than 6 caplets in 24 hours

Route of Administration: Oral

In Vitro Use Guide

A time- and concentration-dependent decrease in intracellular GSH occurred in freshly isolated type II pneumocytes and alveolar macrophages exposed to subtoxic (

Substance Class	Chemical Created by `admin` on `Fri Jun 25 21:05:34 UTC 2021` Edited by `admin` on `Fri Jun 25 21:05:34 UTC 2021`
Record UNII	362O9ITL9D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ACETAMINOPHEN

Official Name

English

ACETAMINOPHEN COMPONENT OF MEDIGESIC PLUS

Common Name

English

NORCET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF ROXICET

Common Name

English

ACETAMINOPHEN [USP]

Common Name

English

ACETAMINOPHEN COMPONENT OF TALACEN

Common Name

English

ACETAMINOPHEN [VANDF]

Common Name

English

PHENAPHEN

Common Name

English

NSC-109028

Code

English

DURADYNE DHC COMPONENT ACETAMINOPHEN

Common Name

English

TRIAPRIN COMPONENT ACETAMINOPHEN

Common Name

English

PERCOCET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF DURADYNE DHC

Common Name

English

ACETAMINOPHEN COMPONENT OF BANCAP

Common Name

English

ACETAMINOPHEN [INCI]

Common Name

English

PARACETAMOLUM [WHO-IP LATIN]

Common Name

English

TRIAD COMPONENT ACETAMINOPHEN

Common Name

English

ESGIC COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF SYNALGOS-DC-A

Common Name

English

DHC PLUS COMPONENT ACETAMINOPHEN

Common Name

English

PARACETAMOL [WHO-IP]

Common Name

English

PERFALGAN

Brand Name

English

ACETAMINOPHEN [ORANGE BOOK]

Common Name

English

ACETAMINOPHEN COMPONENT OF LORTAB

Common Name

English

LORCET-HD COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMIDE, N-(4-HYDROXYPHENYL)-

Systematic Name

English

DAFALGAN

Brand Name

English

ACETAMINOPHEN COMPONENT OF FIORICET

Common Name

English

SEDAPAP COMPONENT ACETAMINOPHEN

Common Name

English

OFIRMEV

Brand Name

English

MEDIGESIC PLUS COMPONENT ACETAMINOPHEN

Common Name

English

DRIXORAL PLUS COMPONENT ACETAMINOPHEN

Common Name

English

P-HYDROXY-ACETANILID

Common Name

English

PARACETAMOL [MART.]

Common Name

English

4'-HYDROXYACETANILIDE

Systematic Name

English

VICODIN COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF BUCET

Common Name

English

EFFERALGAN

Brand Name

English

ZYDONE COMPONENT ACETAMINOPHEN

Common Name

English

NORCO COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN [MI]

Common Name

English

FEMCET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF OXYCET

Common Name

English

PARACETAMOL [EP MONOGRAPH]

Common Name

English

ALLAY COMPONENT ACETAMINOPHEN

Common Name

English

BIOCETAMOL

Common Name

English

ACETAMINOPHEN COMPONENT OF DHC PLUS

Common Name

English

ACETAMINOPHEN COMPONENT OF ROXILOX

Common Name

English

PARACETAMOL [IARC]

Common Name

English

ACETAMINOPHEN COMPONENT OF NORCO

Common Name

English

LORTAB COMPONENT ACETAMINOPHEN

Common Name

English

NEOPAP

Brand Name

English

ACETAMINOPHEN COMPONENT OF DOLENE AP-65

Common Name

English

ANEXSIA COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF VICODIN

Common Name

English

ACETAMINOPHEN COMPONENT OF WYGESIC

Common Name

English

FIORICET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN [JAN]

Common Name

English

ACETAMINOPHEN [USP-RS]

Common Name

English

ACETAMINOPHEN COMPONENT OF EXCEDRIN

Common Name

English

CODRIX COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN [USP MONOGRAPH]

Common Name

English

PHRENILIN COMPONENT ACETAMINOPHEN

Common Name

English

HY-PHEN COMPONENT ACETAMINOPHEN

Common Name

English

TYCOLET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF TYCOLET

Common Name

English

PARACETAMOL

Official Name

English

ACETAMINOPHEN COMPONENT OF CO-GESIC

Common Name

English

BUCET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF NORCET

Common Name

English

TENCON COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF LORCET-HD

Common Name

English

ACETAMINOPHEN [HSDB]

Common Name

English

ROXICET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF TENCON

Common Name

English

TREZIX COMPONENT ACETAMINOPHEN

Brand Name

English

EXCEDRIN COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF CODRIX

Common Name

English

PARACETAMOL [INN]

Common Name

English

ACETAMINOPHEN COMPONENT OF ALLAY

Common Name

English

TYLENOL

Brand Name

English

ACETAMINOPHEN COMPONENT OF HY-PHEN

Common Name

English

DARVOCET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF TYLOX

Common Name

English

XARTEMIS COMPONENT ACETAMINOPHEN

Brand Name

English

ACETAMINOPHEN COMPONENT OF TRIAD

Common Name

English

NSC-3991

Code

English

ACETAMINOPHEN COMPONENT OF SEDAPAP

Common Name

English

ULTRACET COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF XARTEMIS

Brand Name

English

ANOQUAN COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF ULTRACET

Common Name

English

N-ACETYL-P-AMINOPHENOL

Common Name

English

ACETAMINOPHEN COMPONENT OF ANOQUAN

Common Name

English

ROXILOX COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF BUTAPAP

Common Name

English

ACETAMINOPHEN COMPONENT OF BANCAP HC

Common Name

English

ACETAMINOPHEN COMPONENT OF PERCOCET

Common Name

English

ACETAMINOPHEN COMPONENT OF DARVOCET

Common Name

English

ACETAMINOPHEN COMPONENT OF ANEXSIA

Common Name

English

BUTAPAP COMPONENT ACETAMINOPHEN

Common Name

English

BANCAP HC COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF ZYDONE

Common Name

English

ACETAMINOPHEN COMPONENT OF TRIAPRIN

Common Name

English

DOLIPRANE

Common Name

English

BANCAP COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF DRIXORAL PLUS

Common Name

English

TYLOX COMPONENT ACETAMINOPHEN

Common Name

English

ACETAMINOPHEN COMPONENT OF ESGIC

Common Name

English

CO-GESIC COMPONENT ACETAMINOPHEN

Common Name

English

VERMIDON

Common Name

English

OXYCET COMPONENT ACETAMINOPHEN

Common Name

English

ACEPHEN

Brand Name

English

ACETAMINOPHEN COMPONENT OF PHRENILIN

Common Name

English

WYGESIC COMPONENT ACETAMINOPHEN

Common Name

English

INJECTAPAP

Brand Name

English

SYNALGOS-DC-A COMPONENT ACETAMINOPHEN

Common Name

English

TALACEN COMPONENT ACETAMINOPHEN

Common Name

English

DOLENE AP-65 COMPONENT ACETAMINOPHEN

Common Name

English

PARACETAMOL [WHO-DD]

Common Name

English

ACETAMINOPHEN COMPONENT OF FEMCET

Common Name

English

PANADOL

Brand Name

English

Classification Tree Code System Code

WHO-ATC

N02AJ17